Akumin Announces Completion of Domestication to Delaware

Rhea-AI Summary

Akumin Inc. (NASDAQ: AKU) has successfully completed its change of incorporation from Ontario, Canada, to Delaware, USA, effective September 30, 2022. This process, termed 'Domestication,' was approved by Akumin's shareholders on June 30, 2022. Following this change, Akumin will continue to trade under the stock symbol 'AKU' on both NASDAQ and the Toronto Stock Exchange. The move aims to align Akumin with the General Corporation Law of Delaware, enhancing its operational framework. Further details are available on EDGAR and SEDAR.

Positive

• Completion of Domestication potentially provides a more flexible regulatory environment.
• Continued trading under stock symbol 'AKU' ensures brand consistency.

Negative

• None.

PLANTATION, FLA, Oct. 3, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin") today announced that, effective September 30, 2022, it completed its previously announced change of jurisdiction of incorporation from the Province of Ontario, Canada to the State of Delaware, USA (the "Domestication"). In light of the completion of the Domestication, Akumin is now subject to the General Corporation Law of the State of Delaware. The stock symbol of Akumin on both the NASDAQ Stock Exchange and the Toronto Stock Exchange will continue to be "AKU".

The Domestication was approved by a special resolution of shareholders of Akumin passed at the annual general and special meeting of shareholders held on June 30, 2022 and subsequently by the board of directors of Akumin.

Complete details regarding the Domestication were outlined in the management information circular of Akumin dated May 17, 2022, a copy of which is available at Akumin's profile on EDGAR at www.sec.gov and on www.sedar.com.

About Akumin

Akumin is a national leader in comprehensive outpatient radiology and oncology solutions and a partner of choice for U.S. hospitals, health systems and physician groups. Akumin provides fixed-site outpatient radiology and oncology services through a network of 234 owned and/or operated centers; as well as outpatient radiology and oncology solutions to approximately 1,000 hospitals and health systems across 48 states. Akumin combines clinical and operational expertise with the latest advances in technology and information systems to deliver patient-centered innovation, service standardization and exceptional healthcare value to its patients and partners. For more information, visit www.akumin.com.

View original content:https://www.prnewswire.com/news-releases/akumin-announces-completion-of-domestication-to-delaware-301638385.html

SOURCE Akumin Inc.

FAQ

What is the significance of Akumin's Domestication to Delaware?

The Domestication allows Akumin to align with Delaware's General Corporation Law, which is known for its business-friendly regulations.

When did Akumin complete its change of incorporation?

Akumin completed its change of incorporation on September 30, 2022.

Will Akumin's stock symbol change after the Domestication?

No, Akumin will continue to trade under the stock symbol 'AKU'.

Who approved the Domestication of Akumin?

The Domestication was approved by a special resolution of Akumin's shareholders on June 30, 2022.